OTAVA Ltd., founded in 1997, is an international chemistry company supporting drug discovery, agrochemical research, and life-science innovation. OTAVA offers screening compounds, chemical building blocks, focused and target-specific libraries, custom synthesis, contract research, and molecular modeling services. Its portfolio includes more than 300,000 HTS compounds, 400+ target-focused libraries, fragment and CNS-focused collections, and extensive building-block resources for medicinal chemistry programs. With expertise in synthetic organic chemistry, computational chemistry, and rational library design, OTAVA helps pharmaceutical, biotech, academic, and government research teams accelerate hit identification, hit-to-lead optimization, and discovery of biologically active compounds. A key area of OTAVA’s scientific focus is kinase-directed drug discovery, supported by a broad portfolio of protein kinase targeted libraries and related research tools
Looking for a particular OTAVA Ltd employee's phone or email?
The OTAVA Ltd annual revenue was $12 million in 2026.
Mykola Yarmolyuk is the Director of OTAVA Ltd.
4 people are employed at OTAVA Ltd.
OTAVA Ltd is based in Vaughan, Ontario.
The NAICS codes for OTAVA Ltd are [541, 5417, 54, 54171, 541714].
The SIC codes for OTAVA Ltd are [87, 873].